Literature DB >> 22564107

Treg lymphocytes in autoimmune uveitis.

Simona Ruggieri1, Maria Antonia Frassanito, Rosanna Dammacco, Silvana Guerriero.   

Abstract

PURPOSE: To evaluate circulating CD4(+)CD25(+) regulatory T-cell populations in patients with autoimmune uveitis and to assess whether T-regulatory cell populations correlate with clinical features.
METHODS: Sixty-four patients with noninfectious uveitis were enrolled. Following isolation and purification of peripheral blood mononuclear cells, Tregs were analyzed by assessing FOXP3 expression on T cells with an APC anti-human FOXP3 staining kit. Samples were simultaneously stained with anti-CD25-PeCy7, anti-CD3-FITC, anti-CD4-PercP, and anti-CD152 (CTLA-4)-PE monoclonal antibodies.
RESULTS: A decrease in CD4(+)CD25(+)FOXP3(+) T cells was detected in patients with active uveitis compared with healthy controls (p < .05). In patients achieving clinical remission, the percentage of CD4(+)CD25(+)FOXP3(+) T cells increased up to values comparable to those of healthy controls, in step with an increased expression of CTLA4.
CONCLUSION: Therapy of autoimmune uveitis results in the increase of T-regulatory lymphocyte population and restoration of their functional state. These changes are likely to contribute to the patients' clinical improvement or disease regression.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22564107     DOI: 10.3109/09273948.2012.681830

Source DB:  PubMed          Journal:  Ocul Immunol Inflamm        ISSN: 0927-3948            Impact factor:   3.070


  17 in total

1.  Lactobacillus casei regulates differentiation of Th17/Treg cells to reduce intestinal inflammation in mice.

Authors:  Kai Wang; Hao Dong; Yu Qi; Zhihua Pei; Shushuai Yi; Xiaojie Yang; Yanli Zhao; Fanxing Meng; Shouping Yu; Tiezhong Zhou; Guixue Hu
Journal:  Can J Vet Res       Date:  2017-04       Impact factor: 1.310

Review 2.  Uveitis associated with juvenile idiopathic arthritis.

Authors:  Ethan S Sen; Andrew D Dick; Athimalaipet V Ramanan
Journal:  Nat Rev Rheumatol       Date:  2015-03-31       Impact factor: 20.543

Review 3.  Autoimmune uveitis: clinical, pathogenetic, and therapeutic features.

Authors:  Marcella Prete; Rosanna Dammacco; Maria Celeste Fatone; Vito Racanelli
Journal:  Clin Exp Med       Date:  2015-03-28       Impact factor: 3.984

4.  Tregs in Autoimmune Uveitis.

Authors:  Zhaohao Huang; Wenli Li; Wenru Su
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

Review 5.  Statins as anti-inflammatory agents: A potential therapeutic role in sight-threatening non-infectious uveitis.

Authors:  Rose Gilbert; Ahmed Al-Janabi; Oren Tomkins-Netzer; Sue Lightman
Journal:  Porto Biomed J       Date:  2017-03-01

Review 6.  Resolution of uveitis.

Authors:  Gerhild Wildner; Maria Diedrichs-Möhring
Journal:  Semin Immunopathol       Date:  2019-10-07       Impact factor: 9.623

Review 7.  TIGIT as a Promising Therapeutic Target in Autoimmune Diseases.

Authors:  Chenran Yue; Sheng Gao; Shuting Li; Zhouhang Xing; Hengrong Qian; Ying Hu; Wenqian Wang; Chunyan Hua
Journal:  Front Immunol       Date:  2022-06-03       Impact factor: 8.786

8.  Differential distribution of steroid hormone signaling networks in the human choroid-retinal pigment epithelial complex.

Authors:  Sydney M Galindez; Andrew Keightley; Peter Koulen
Journal:  BMC Ophthalmol       Date:  2022-10-20       Impact factor: 2.086

9.  Notch signalling suppresses regulatory T-cell function in murine experimental autoimmune uveitis.

Authors:  Hua Rong; Hongjie Shen; Yueli Xu; Hai Yang
Journal:  Immunology       Date:  2016-09-23       Impact factor: 7.397

10.  Galectin-8 Ameliorates Murine Autoimmune Ocular Pathology and Promotes a Regulatory T Cell Response.

Authors:  James F Sampson; Eiichi Hasegawa; Lama Mulki; Amol Suryawanshi; Shuhong Jiang; Wei-Sheng Chen; Gabriel A Rabinovich; Kip M Connor; Noorjahan Panjwani
Journal:  PLoS One       Date:  2015-06-30       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.